(Q41594644)

4 October 2017

1 reference

title

Epstein-Barr virus oncogenesis (English)

1 reference

4 October 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9298328

16 November 2024

al-Homsi AS

1 reference

4 October 2017

H. Knecht

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9298328

16 November 2024

C. Berger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9298328

16 November 2024

A. S. al-Homsi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9298328

16 November 2024

C. McQuain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9298328

16 November 2024

P. Brousset

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9298328

16 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9298328

16 November 2024

publication date

1 July 1997

1 reference

4 October 2017

July 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9298328

full work available at URL

16 November 2024

https://api.elsevier.com/content/article/PII:S1040842897000164?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

https://api.elsevier.com/content/article/PII:S1040842897000164?httpAccept=text/plain

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Critical Reviews in Oncology Hematology

16 November 2024

published in

1 reference

4 October 2017

1 reference

4 October 2017

1 reference

4 October 2017

page(s)

117-135

1 reference

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Long-term remissions following one and two-dose chemotherapy for African lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus in lymphomas: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Latent membrane protein 1: a key oncogene in EBV-related carcinogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus immortalizing genes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus infection of T cells: implications for altered T-lymphocyte activation, repertoire development and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Are particular Epstein-Barr virus strains linked to disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

B cell activation and the establishment of Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Characterization of an Epstein-Barr virus receptor on human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Immunoglobulin A-Induced Shift of Epstein-Barr Virus Tissue Tropism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The cytoplasmic C-terminal domain but not the N-terminal domain of latent membrane protein 1 of Epstein-Barr virus is essential for B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Proposed NF- B/I B family nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

TRAF6 is a signal transducer for interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Characterization of 5'-upstream sequence of the latent membrane protein 1 (LMP-1) gene of an Epstein-Barr virus identified in nasopharyngeal carcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Sequence variation of latent membrane protein-1 of Epstein-Barr virus strains associated with hairy leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Pathological, Immunological, and Molecular Features of Hodgkin's Disease Associated with HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Expression of epstein-barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Hodgkin's disease after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

EBV-associated lymphoproliferative syndrome with a distinct 69 base-pair deletion in the LMP-1 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

EBV gene expression in an NPC-related tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus: adaptation to a life within the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Introduced T cell receptor variable region gene segments recombine in pre-B cells: evidence that B and T cells use a common recombinase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The V(D)J recombination activating gene, RAG-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Mechanism of antigen-driven selection in germinal centres

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus latent and replicative gene expression in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

A Transformation-Incompetent, Nuclear Antigen 2-Deleted Epstein-Barr Virus Associated with Replicative Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Structure and function of simian virus 40 large tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Reed-Sternberg cells and "bystander" lymphocytes in lymph nodes affected by Hodgkin's disease are infected with different strains of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2897%2900016-4

7 January 2021

Retracted: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.93.24.14053

Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

T cell recognition of Epstein-Barr virus associated lymphomas

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Immortalizing Genes of Epstein-Barr Virus

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

DNA sequence analysis of the EcoRI Dhet fragment of B95-8 Epstein-Barr virus containing the terminal repeat sequences

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells

16 November 2024

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody

16 November 2024

120

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Epstein-Barr virus infection in carcinoma of the salivary gland

16 November 2024

122

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia

16 November 2024

123

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders

16 November 2024

151

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein

16 November 2024

157

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2

16 November 2024

160

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population

16 November 2024

163

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease

16 November 2024

175

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

16 November 2024

180

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

16 November 2024

184

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions

16 November 2024

189

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Epstein-Barr virus-associated gastric adenocarcinoma

16 November 2024

218

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma

16 November 2024

220

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

16 November 2024

221

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours

16 November 2024

222

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

16 November 2024

223

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation

16 November 2024

228

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein

16 November 2024

240

1 reference

https://api.crossref.org/works/10.1016/S1040-8428(97)00016-4

16 November 2024

Identifiers

1 reference

4 October 2017

1 reference